TP53 and chronic myelogenous leukemia, BCR-ABL1 positive: While the viability of lymphocytes was maintained at the control level even after 48 h of DAC + SAHA combination treatment, both cell lines, wtp53 CML-T1 and p53-null HL-60, showed significant viability decrease (P < 0.001).